Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips and Prisma Health sign multi-year, long-term strategic partnership to innovate healthcare across the enterprise and unlock the power of patient data

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL

Koninklijke Philips N.V. Announces Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Philips launches offering of Green and Sustainability Innovation Notes and a Series of Liability Management Transactions

VIENNA--(BUSINESS WIRE)--Speech Processing Solutions, the global leader in professional speech-to-text solutions sold under the Philips brand, has teamed up with an exciting American start-up named Sembly AI. Together they'll unite to provide high-quality microphones and smart meeting technology. Sembly goes beyond simple speech recognition and offers users instant searchable meeting transcripts, highlights key discussion moments, and creates summaries. Every meeting, perfectly captured The new

Philips Speech Teams Up With Sembly AI to Launch a Brand-new Speech Technology Solution for Meetings

Koninklijke Philips' (PHG) Q1 top- and bottom-line results reflect negative impact of supply chain constraints and consequences of the Respironics field action.

Philips' (PHG) Q1 Earnings Down Y/Y on Supply Chain Constraints

Koninklijke Philips N.V. (NYSE:PHG ) Q1 2022 Earnings Conference Call April 25, 2022 4:00 AM ET CompanyParticipants Leandro Mazzoni - Head of Investor Relations Frans van Houten - Chairman & Chief Executive Officer Abhijit Bhattacharya - Executive Vice President & Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Veronika Dubajova - Goldman Sachs David Adlington - JPMorgan Julien Dormois - BNP Paribas Graham Doyle - UBS Delphine Le Louet - Societe General James Vane-Tempest - Jefferies Kate Kalashnikova - Citi Sezgi Oezener - HSBC Falko Friedrichs - Deutsche Bank Max Yates - Crédit Suisse Operator Welcome to the Royal Philips First Quarter 2022 Results Conference Call on Monday, April 25, 2022.

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q1 2022 Results - Earnings Call Transcript

Koninklijke Philips NV (NYSE: PHG) shares are trading lower by 12.16% at $26.65 after the company reported first-quarter financial results. Among the highlights from the first quarter, Koninklijke Philips highlighted: Group sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on.

Why Koninklijke Philips Shares Are Falling

Koninklijke Philips NV stock (AMS: PHIA) is down more than 10% on Monday after the health-technology company reported a net loss for its fiscal first quarter. Notable figures in Philips Q1 earnings report Lost €151 million ($162 million) versus the year-ago figure of €39 million profit.

Philips stock opened 10% down on Monday: explained here

Philips on Monday reported net losses of over 150 million euros in the first quarter of 2022 as the Dutch health technology firm battled a faulty respirator recall and supply chain problems.

Philips take hit by supply problems, respirator recall

Dutch health technology company Philips on Monday said first-quarter core profit dropped about a third from a year prior to 243 million euros ($261.8 million), hit by an ongoing global shortage of parts and a massive recall of ventilators.

Philips Q1 core profit plunges as supply chain problems continue

Philips delivers Q1 sales of EUR 3.9 billion, with good demand driving 5% comparable order intake growth

Philips Respironics issues voluntary recall notification/field safety notice* for the V60 ventilator product family

First patients ‘filter free' after laser-assisted Inferior Vena Cava (IVC) filter removal with Philips CavaClear

Philips signs long-term strategic partnership with Oulu University Hospital Finland to deliver advanced image-guided specialist care

Late-breaking data at ACC.22 with over 1 million patients demonstrates a major gap in guideline adherence resulting in higher mortality for patients with infected CIEDs

Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to its existing healthcare portfolio.

Philips' (PHG) Innovative Product Suite to Cheer Investors

Clearway Energy

Boost your passive income stream with this 3.7%-yielding basket of dividend stocks.

Got $500? 3 High-Yield Dividend Stocks to Buy in April

Philips showcases new innovations in the treatment of heart rhythm disorders at EHRA 2022

Philips adds to its cardiology suite of solutions at ACC 2022 with innovations to help improve patient outcomes, experiences, and care pathway effectiveness

Philips enables seamless echocardiography workflows with the launch of Ultrasound Workspace at ACC 2022

Philips Image Guided Therapy System – Azurion – with Ambient Experience and FlexVision display helps reduce patient anxiety during interventional procedures

Philips' (PHG) innovative lung cancer diagnosis and treatment solution, Philips Lung Suite, is witnessing rapid adoption by clinical partners globally

Philips' (PHG) Lung Suite 3D Imaging Solution Gains Traction

Philips expands network of clinical partners to set new standard of care for the early diagnosis and treatment of lung cancer

Philips convenes the Annual General Meeting of Shareholders 2022

Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas

Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care

News for Royal Philips Stock (PHG)